Duck Vaccines

Duck Vaccines Market Outlook

The global duck vaccines market is projected to reach approximately USD 1.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2025 to 2035. This growth can be attributed to the rising need for disease prevention in domestic and commercial duck farming, driven by the increasing demand for duck meat and eggs around the world. Additionally, as avian diseases pose significant threats to poultry health and productivity, the importance of vaccination programs for ducks is becoming more prominent. The increasing awareness among farmers about the benefits of vaccination, coupled with advancements in vaccine development technology, is further expected to propel the market growth. Moreover, the rise in duck farming in developing regions, as well as government initiatives supporting poultry health, are contributing to the positive outlook of the duck vaccines market.

Growth Factor of the Market

Several factors are driving the growth of the duck vaccines market. First and foremost, the increasing incidence of viral and bacterial diseases in ducks has raised awareness of the need for effective vaccination, leading to heightened market demand. Additionally, the expansion of large-scale duck farming operations is pushing for efficient health management practices, including routine vaccination to prevent outbreaks. Moreover, advancements in biotechnology are enabling the development of more effective and targeted vaccines, thereby improving overall efficacy and reducing the occurrence of adverse effects. Consumer preferences for healthier and safer poultry products are further influencing the demand for vaccines, as vaccinated ducks are less likely to carry diseases. Lastly, the growing trend of biosecurity measures in farming practices to prevent disease transmission is also enhancing the adoption of duck vaccines.

Key Highlights of the Market

• The global duck vaccines market is expected to grow at a CAGR of 8.5% from 2025 to 2035.
• Live attenuated vaccines are anticipated to hold the largest market share due to their efficacy and cost-effectiveness.
• Veterinary clinics are the primary distribution channel, catering to the majority of duck vaccination needs.
• Asia Pacific is projected to dominate the market, contributing significantly to the overall revenue due to its extensive duck farming practices.
• Technological advancements in vaccine formulations are expected to enhance vaccine efficacy and safety.

By Product Type

Live Attenuated Vaccines:

Live attenuated vaccines play a crucial role in the duck vaccines market due to their effectiveness in stimulating a strong immune response. These vaccines contain live but weakened forms of pathogens, which help in building immunity without causing the disease. Their ability to provide long-lasting protection makes them a preferred choice among veterinarians and farmers. The ease of administration and cost-effectiveness further contribute to their popularity, as they often require fewer doses compared to other types of vaccines. These factors combined position live attenuated vaccines as a dominant product type in the market, meeting the needs of both small-scale and large-scale duck farming operations.

Inactivated Vaccines:

Inactivated vaccines, which use killed pathogens to stimulate an immune response, are also significant in the duck vaccines market. These vaccines are known for their safety profile, as they do not contain live pathogens that could potentially cause disease. Inactivated vaccines often require booster doses to maintain immunity, making them a suitable option for farmers looking for a reliable but different approach to disease prevention. Their application is crucial in controlling diseases like duck viral hepatitis and duck flu, where the consequences of outbreaks can be devastating. As a result, the market for inactivated vaccines is expected to see steady growth, complementing the offerings of live attenuated vaccines.

Recombinant Vaccines:

Recombinant vaccines are at the forefront of technological advancement in the duck vaccines market. These vaccines leverage genetic engineering to produce antigens in a host organism, which are then used to stimulate an immune response in ducks. The use of recombinant technology allows for enhanced specificity and the potential for individualized vaccine development. As such, recombinant vaccines are gaining popularity as they can provide targeted protection against specific pathogens, thus improving overall health outcomes in duck populations. The increasing focus on biosecurity and disease prevention in poultry farming is expected to boost the adoption of recombinant vaccines in the coming years.

DNA Vaccines:

DNA vaccines represent a novel approach in the duck vaccines market, utilizing genetically engineered DNA to provoke an immune response. These vaccines are advantageous due to their stability and ease of storage and transport compared to traditional vaccines. Additionally, DNA vaccines can stimulate both humoral and cellular immunity, providing a robust defense against infectious diseases. The ongoing research and development in this area suggest that DNA vaccines could revolutionize poultry health management by offering long-term protection and reducing the risk of disease outbreaks. As this technology matures, the market for DNA vaccines is poised for significant growth.

Vector Vaccines:

Vector vaccines utilize a harmless virus or bacterium as a delivery system to introduce specific antigens from pathogenic organisms into ducks. This innovative approach helps in eliciting a strong immune response without the risk of disease associated with other vaccine types. Vector vaccines offer the advantage of inducing both humoral and cellular immunity, which is critical for comprehensive disease protection. As duck farming evolves and the need for effective vaccination strategies grows, vector vaccines are expected to gain traction in the market. Their unique mechanism of action and potential for simultaneous vaccination against multiple pathogens make them an exciting area for future development.

By Application

Duck Viral Hepatitis:

Duck viral hepatitis is a serious disease that can cause significant economic losses in duck farming. Vaccination against this disease is crucial for maintaining healthy duck populations and ensuring productivity. The prevalence of this disease has driven the development of effective vaccines, which are designed to protect ducks from the virus that causes hepatitis. Vaccines targeting duck viral hepatitis not only help in controlling outbreaks but also enhance the overall health of duck populations, improving growth rates and reproductive performance. As awareness grows regarding the consequences of this disease, the market for vaccines specifically designed for duck viral hepatitis is expected to witness substantial growth.

Duck Plague:

Disease prevention is vital in duck farming, and duck plague is one of the most significant threats to duck health. Vaccines for duck plague are essential to mitigate the impact of this highly contagious disease, which can result in high mortality rates in affected flocks. These vaccines are designed to provide immunity and protect ducks against the virus responsible for the disease, thereby reducing the incidence of outbreaks. As the demand for duck meat and eggs rises, so does the need for effective vaccination strategies to ensure flock health and productivity. Consequently, the market for duck plague vaccines is projected to expand in line with these needs.

Duck Parvovirus Infection:

Duck parvovirus infection is another critical concern for poultry health, leading to significant economic implications for farmers. Vaccination plays a vital role in controlling the spread of this disease and protecting duck populations. The development of vaccines targeting duck parvovirus has become an essential aspect of health management in duck farming. These vaccines are designed to prevent infection and reduce the severity of disease symptoms in affected ducks. With the increasing recognition of the importance of disease prevention measures, the market for vaccines against duck parvovirus infection is expected to grow significantly, supporting the health and longevity of duck flocks.

Duck Influenza:

Duck influenza poses a serious threat not only to duck populations but also to human health and the poultry industry as a whole. Vaccination is a critical strategy in controlling this disease, as it can help mitigate the risk of outbreaks that may have broader implications. Vaccines targeting duck influenza are designed to stimulate an immune response and provide protection against various strains of the virus. The increasing focus on biosecurity measures and disease prevention in duck farming has underscored the importance of vaccines against duck influenza. As a result, this segment of the market is anticipated to grow, driven by the need for effective vaccination strategies to protect both animal and public health.

Other Diseases:

In addition to the prominent diseases mentioned, ducks are susceptible to various other infections that can adversely affect their health and productivity. Vaccination against these diseases is crucial for comprehensive health management in duck farming. As farmers become increasingly aware of the benefits of vaccinating against a broad spectrum of diseases, the market for vaccines targeting these other diseases is likely to expand. This includes vaccines against bacterial infections and other viral pathogens that may arise in specific geographical regions or under certain farming conditions. The growth potential in this segment reflects the evolving landscape of duck vaccination and the importance of disease prevention in sustaining healthy duck populations.

By Distribution Channel

Veterinary Clinics:

Veterinary clinics serve as a primary distribution channel for duck vaccines, providing essential healthcare services to farmers. Clinics are often equipped with knowledgeable staff who can guide farmers on the appropriate vaccination protocols based on the specific health needs of their flocks. The accessibility of veterinary clinics makes them a convenient option for farmers to obtain vaccines and receive proper administration advice. As the importance of vaccination in maintaining flock health becomes more recognized, the role of veterinary clinics as a distribution point for duck vaccines is expected to grow, enhancing overall market dynamics.

Veterinary Hospitals:

Veterinary hospitals play a crucial role in the distribution of duck vaccines, especially for larger farming operations that require comprehensive health management services. These facilities often have advanced resources and expertise, enabling them to handle complex cases and provide specialized care. The presence of veterinary hospitals enhances the reliability of vaccine distribution, ensuring that farmers have access to high-quality products and professional support. As large-scale duck farming continues to expand, the importance of veterinary hospitals in the distribution of vaccines is likely to increase, contributing to market growth.

Online Stores:

Online stores are rapidly emerging as an important distribution channel for duck vaccines, driven by the growing trend of e-commerce across various sectors. The convenience of online shopping allows farmers to access a wide range of vaccine options from the comfort of their homes. This channel also provides the ability to compare prices, read customer reviews, and access additional resources related to vaccine administration and poultry health. As internet connectivity improves and online shopping becomes more prevalent in rural areas, the market for duck vaccines distributed through online channels is anticipated to see significant growth.

Retail Pharmacies:

Retail pharmacies contribute to the accessibility of duck vaccines, offering an alternative distribution channel for farmers. These pharmacies can stock vaccines that are commonly used for poultry health, making it easier for farmers to obtain necessary products without having to travel far. The integration of veterinary products into retail pharmacies has the potential to streamline the vaccination process and encourage proactive health management among duck farmers. As more pharmacies begin to carry agricultural products, the role of retail pharmacies in the duck vaccines market is expected to expand, increasing availability and convenience.

By Ingredient Type

Salmonella:

Salmonella is a significant concern in poultry health, and vaccines targeting this bacteria are essential for preventing infections in ducks. Vaccines containing components that combat Salmonella aim to reduce the risk of disease transmission, enhance overall flock health, and protect consumers from foodborne illnesses. The increasing awareness of food safety and the significance of disease prevention in duck farming are driving the demand for Salmonella vaccines. As the public's focus on safe poultry products grows, the market for vaccines targeting this ingredient type is projected to expand, benefiting both farmers and consumers.

E. coli:

E. coli infections can lead to severe health issues in ducks, making it essential to vaccinate against this pathogen. Vaccines targeting E. coli are designed to boost the immune response of ducks, helping to prevent infections that can impact growth and productivity. The rising incidence of E. coli-related diseases in poultry has underscored the need for effective vaccination strategies. As farmers strive to maintain the health of their flocks and minimize production losses, the market for E. coli vaccines is expected to see significant growth in line with increasing awareness of disease management practices.

Pasteurella multocida:

Pasteurella multocida is responsible for a variety of respiratory infections in ducks, highlighting the need for vaccines that can effectively combat this pathogen. Vaccines developed to target Pasteurella multocida play a vital role in maintaining the health of duck populations and ensuring productivity. With the ongoing focus on biosecurity measures and disease prevention, the demand for vaccines targeting this ingredient is increasing. The market for Pasteurella multocida vaccines is projected to expand as more farmers recognize the importance of vaccination in promoting flock health and reducing the incidence of respiratory diseases.

Clostridium perfringens:

Clostridium perfringens is another concerning pathogen that can lead to significant health issues in ducks, particularly enteritis. Vaccines targeting this bacterium are critical for preventing infections and promoting overall gastrointestinal health in duck populations. The increasing recognition of the economic impact of intestinal diseases in poultry farming has spurred the development and adoption of vaccines against Clostridium perfringens. As the market continues to evolve, the demand for vaccines protecting against this ingredient type is expected to gain momentum, reflecting the ongoing efforts to improve poultry health management.

Avibacterium paragallinarum:

Avibacterium paragallinarum is a lesser-known but significant pathogen affecting duck populations, causing respiratory issues and reduced productivity. Vaccines developed to target this bacterium are essential for preventing outbreaks and ensuring the health of duck flocks. As farmers become more aware of the various pathogens that can impact their operations, the demand for vaccines that protect against Avibacterium paragallinarum is expected to grow. The development of effective vaccines against this ingredient type will further support the overall health management strategies deployed in duck farming.

By Region

The North American duck vaccines market is anticipated to witness steady growth, driven by the increasing demand for duck meat and eggs. The region's focus on animal health and welfare has led to the implementation of effective vaccination programs, ensuring the protection of duck populations against prevalent diseases. With a considerable number of commercial duck farms operating in the United States and Canada, the adoption of vaccines targeting diseases such as duck viral hepatitis and duck influenza is expected to increase. The North American market is projected to grow at a CAGR of 7% during the forecast period, reflecting the ongoing commitment to improving poultry health in the region.

In Europe, the duck vaccines market is also poised for growth as the region's poultry industry invests in biosecurity measures and health management strategies. The increasing incidence of infectious diseases and the demand for high-quality duck products are driving the need for effective vaccination solutions. Countries such as France and Poland, which have established duck farming practices, are expected to see significant market growth. The European market's emphasis on sustainable farming practices and the implementation of veterinary health programs are anticipated to bolster the demand for duck vaccines, aligning with the market's overall positive outlook.

Opportunities

The duck vaccines market presents several opportunities for growth, primarily driven by the expanding global demand for poultry products. With an increasing population and a growing preference for duck meat due to its unique flavor and nutritional benefits, there is a heightened focus on ensuring the health and productivity of duck populations. This trend translates to a surge in vaccination efforts among farmers, who are recognizing the critical role vaccines play in maintaining flock health and maximizing production. Additionally, advancements in vaccine development technologies, such as recombinant and DNA vaccines, are paving the way for more effective and targeted solutions. These innovations not only enhance the efficacy of vaccines but also boost farmer confidence in vaccination programs, ultimately driving market growth.

Another significant opportunity lies in the adoption of integrated health management practices among duck farmers. As biosecurity measures become increasingly prioritized, the emphasis on vaccination as a key component of disease prevention strategies will continue to grow. This presents a favorable environment for vaccine manufacturers to collaborate with farmers and veterinarians to develop tailored vaccination programs that address specific health challenges faced by duck populations. Furthermore, emerging markets in Asia Pacific and Latin America are witnessing a rise in duck farming activities, creating new avenues for vaccine distribution and increasing the overall market scope. With the convergence of these factors, the duck vaccines market is well-positioned for sustained growth and innovation.

Threats

Despite the promising outlook for the duck vaccines market, several threats could impact its growth trajectory. One primary concern is the potential for vaccine resistance, which may arise due to the overuse or misuse of vaccines in duck farming. If pathogens develop resistance to existing vaccines, it could lead to a resurgence in diseases that are currently manageable, undermining the effectiveness of vaccination programs. Additionally, fluctuations in duck farming practices and market dynamics, driven by changing consumer preferences or economic challenges, may affect the overall demand for vaccines. Such fluctuations could lead to instability in the market, making it essential for manufacturers to adapt to evolving market conditions.

Moreover, regulatory challenges and compliance issues could pose significant hurdles for vaccine manufacturers. The veterinary pharmaceutical industry is subject to strict regulations that govern vaccine development, approval, and distribution. Any changes in regulatory frameworks or increased scrutiny may slow down the introduction of new vaccines, impacting market growth. Furthermore, the presence of counterfeit or substandard vaccines in some regions poses a risk to both animal health and consumer safety, potentially undermining confidence in vaccination programs. Addressing these challenges will require collaboration between manufacturers, regulatory bodies, and farmers to ensure the availability of effective and safe vaccines.

Competitor Outlook

• Zoetis Inc.
• Merck Animal Health
• Cegelec
• Intervet International B.V.
• Boehringer Ingelheim
• Vetoquinol S.A.
• Huvepharma
• Virbac
• Kemin Industries, Inc.
• Phibro Animal Health Corporation
• Alltech, Inc.
• Elanco Animal Health
• China Animal Husbandry Group
• Hester Biosciences Ltd.
• Indo American Hybrid Seeds Ltd.

The competitive landscape of the duck vaccines market is characterized by a mix of established players and emerging companies seeking to capture market share. Key players are continuously investing in research and development to innovate and improve vaccine formulations, ensuring they meet the evolving needs of duck farmers. Collaborations and partnerships among companies, research institutions, and agricultural organizations are becoming increasingly common as stakeholders recognize the importance of integrated health solutions for duck populations. In addition to product innovation, companies are focusing on expanding their distribution channels and enhancing customer engagement to drive sales and brand loyalty.

Zoetis Inc. stands out as a leading player in the market, known for its extensive portfolio of animal health products, including vaccines tailored for poultry. The company's commitment to research and development has enabled it to introduce vaccines that provide effective protection against various duck diseases. Similarly, Merck Animal Health has a strong presence in the duck vaccines segment, offering a range of solutions aimed at improving overall flock health. The company's ongoing efforts to enhance vaccine efficacy through scientific advancements position it well in the competitive landscape.

Another notable player is Boehringer Ingelheim, which has established itself as a key provider of poultry vaccines, including those for ducks. The company's focus on developing innovative vaccination strategies and enhancing biosecurity measures has contributed to its reputation as a trusted partner for duck farmers. Additionally, emerging companies such as Huvepharma and Hester Biosciences Ltd. are gaining traction in the market by offering cost-effective vaccine options and leveraging local expertise to address regional health challenges. As the duck vaccines market continues to evolve, these companies, along with established players, will play a pivotal role in shaping the industry's future.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Virbac
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Cegelec
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Huvepharma
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Zoetis Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Alltech, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Vetoquinol S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Merck Animal Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Boehringer Ingelheim
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Elanco Animal Health
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Kemin Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hester Biosciences Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Intervet International B.V.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 China Animal Husbandry Group
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Indo American Hybrid Seeds Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Phibro Animal Health Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Duck Vaccines Market, By Application
    • 6.1.1 Duck Viral Hepatitis
    • 6.1.2 Duck Plague
    • 6.1.3 Duck Parvovirus Infection
    • 6.1.4 Duck Influenza
    • 6.1.5 Other Diseases
  • 6.2 Duck Vaccines Market, By Product Type
    • 6.2.1 Live Attenuated Vaccines
    • 6.2.2 Inactivated Vaccines
    • 6.2.3 Recombinant Vaccines
    • 6.2.4 DNA Vaccines
    • 6.2.5 Vector Vaccines
  • 6.3 Duck Vaccines Market, By Ingredient Type
    • 6.3.1 Salmonella
    • 6.3.2 E. coli
    • 6.3.3 Pasteurella multocida
    • 6.3.4 Clostridium perfringens
    • 6.3.5 Avibacterium paragallinarum
  • 6.4 Duck Vaccines Market, By Distribution Channel
    • 6.4.1 Veterinary Clinics
    • 6.4.2 Veterinary Hospitals
    • 6.4.3 Online Stores
    • 6.4.4 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Duck Vaccines Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Duck Vaccines market is categorized based on

By Product Type

• Live Attenuated Vaccines
• Inactivated Vaccines
• Recombinant Vaccines
• DNA Vaccines
• Vector Vaccines

By Application

• Duck Viral Hepatitis
• Duck Plague
• Duck Parvovirus Infection
• Duck Influenza
• Other Diseases

By Distribution Channel

• Veterinary Clinics
• Veterinary Hospitals
• Online Stores
• Retail Pharmacies

By Ingredient Type

• Salmonella
• E. coli
• Pasteurella multocida
• Clostridium perfringens
• Avibacterium paragallinarum

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Zoetis Inc.
• Merck Animal Health
• Cegelec
• Intervet International B.V.
• Boehringer Ingelheim
• Vetoquinol S.A.
• Huvepharma
• Virbac
• Kemin Industries, Inc.
• Phibro Animal Health Corporation
• Alltech, Inc.
• Elanco Animal Health
• China Animal Husbandry Group
• Hester Biosciences Ltd.
• Indo American Hybrid Seeds Ltd.